Terlipressin (acetate)

产品编号 HY-18482
产品分类 抑制剂
CAS号 914453-96-6
分子式 C52H74N16O15S2.XC2H4O2
分子量 1227.38
品牌 华韵生物
规格 50mg 100mg 250mg
应用 Terlipressin is a prodrug form of the vasopressin peptide lysipressin and a partial agonist of the vasopressin V receptor (K = 0.85 µM). It is also an agonist of vasopressin V and V receptors (Ks = 1.11 and 1.58 µM, respectively). It increases mean arterial pressure (MAP) and decreases mortality in a rat model of uncontrolled hemorrhagic shock when administered at a dose of 15 µg/kg. Terlipressin (2.6 µg/kg per hour), in combination with norepinephrine, improves vascular reactivity and increases survival time in a rat model of cecal ligation and puncture-induced septic shock and a rabbit model of LPS-induced septic shock. It also increases MAP in a rat model of liver cirrhosis with portal hypertension, arterial hypotension, high cardiac output, and low systemic vascular resistance.
品牌 货号 纯度 规格 目录价(CNY) 会员价(CNY) 数量 购物车
华韵生物 HY-18482-50mg 50mg ¥10158.00
华韵生物 HY-18482-100mg 100mg ¥19293.00
华韵生物 HY-18482-250mg 250mg ¥43155.00
COA查询 查询MSDS 大包装询盘
CAS号 914453-96-6
分子式 C52H74N16O15S2.XC2H4O2
分子量 1227.38
纯度 ≥95%
状态 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。
为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。
存储 Pure form：
-20°C，3 years / 4°C，2 years ;
In solvent：
-80°C，6 months / -20°C，1 month ;
背景介绍 Terlipressin is a prodrug form of the vasopressin peptide lysipressin and a partial agonist of the vasopressin V receptor (K = 0.85 µM). It is also an agonist of vasopressin V and V receptors (Ks = 1.11 and 1.58 µM, respectively). It increases mean arterial pressure (MAP) and decreases mortality in a rat model of uncontrolled hemorrhagic shock when administered at a dose of 15 µg/kg. Terlipressin (2.6 µg/kg per hour), in combination with norepinephrine, improves vascular reactivity and increases survival time in a rat model of cecal ligation and puncture-induced septic shock and a rabbit model of LPS-induced septic shock. It also increases MAP in a rat model of liver cirrhosis with portal hypertension, arterial hypotension, high cardiac output, and low systemic vascular resistance.
暂无相关论文！
说明书更新中，请联系业务员索取！
暂无技术文章！
象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group
搜索质检报告(COA)
相关产品
Cyclo(-D-Leu-D-Pro)
274680-11-4
Polyinosinic acid
30918-54-8
DSPE-PEG-CRGD
PEG6000
25322-68-3
PEG4000
25322-68-3
PEG500
25322-68-3
PEG200
25322-68-3
PEG1500
25322-68-3